Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Verve Therapeutics, Inc. | 6,320,905 | reported | 21 Jun 2021 | tx 2+6,320,905−58,528,428 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Jun 2021 | CONVERSION | Verve Therapeutics, Inc. | 6,320,905 | — | |
| 21 Jun 2021 | CONVERSION | Verve Therapeutics, Inc. | 58,528,428 | — | deriv |